| Flutamide studied in …STUDIED_INderived52 of 52show fewer |
|---|
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936390Phase 3 · completed Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03507608early Phase 1 · completed Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01889199Phase 2 · completed Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02918968Phase 4 · completed Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06601205Phase 2/Phase 3 · completed Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. · 52 trials list this drug (5 active) | — | — | Prostatic Intraepithelial Neoplasia,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00930228Phase 1 · unknown Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary Syndrome · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04597099early Phase 1 · unknown Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002889Phase 2 · completed Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054106Phase 1 · completed Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00651326Phase 3 · terminated Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005044Phase 3 · completed Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346578Phase 2 · completed Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy. · 52 trials list this drug (5 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 52 trials list this drug (5 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003653Phase 3 · completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00104741Phase 3 · completed Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004054Phase 3 · completed Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00023829Phase 3 · completed Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030654Phase 3 · completed Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742675Phase 2 · unknown Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003645Phase 3 · terminated Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002633Phase 3 · completed Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00528866Phase 2 · completed Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450463Phase 2 · completed Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002855Phase 3 · completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00223665Phase 2 · completed Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00699907Phase 2 · completed Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer · 52 trials list this drug (5 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002597Phase 3 · completed Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01428193NA · terminated Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00170157Phase 2 · completed Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00769548Phase 3 · completed Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003734Phase 3 · unknown Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006214Phase 2 · completed Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003323Phase 2 · completed Hormone Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011751Phase 3 · completed Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00817739Phase 2 · completed Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c · 52 trials list this drug (5 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01122121Phase 3 · completed Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer · 52 trials list this drug (5 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00729560NA · terminated Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary Syndrome · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00442689NA · completed Metabolic Syndrome in PCOS: Precursors and Interventions · 52 trials list this drug (5 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00767286Phase 3 · completed Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003124Phase 2 · completed Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026377Phase 1 · completed SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028769Phase 2 · completed S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003517Phase 2 · withdrawn Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512668Phase 1 · terminated Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer · 52 trials list this drug (5 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388804Phase 3 · terminated External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003026Phase 3 · completed Hormone Therapy in Treating Patients With Advanced Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002881Phase 3 · completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer · 52 trials list this drug (5 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |